Purification, physicochemical properties, and statistical optimization of fibrinolytic enzymes especially from fermented foods: A comprehensive review

被引:34
作者
Ali, Ali Muhammed Moula [1 ]
Bavisetty, Sri Charan Bindu [2 ]
机构
[1] King Mongkuts Inst Technol Ladkrabang, Fac Food Ind, Dept Food Sci & Technol, Bangkok 10520, Thailand
[2] King Mongkuts Inst Technol Ladkrabang, Fac Food Ind, Dept Fermentat Technol, Bangkok 10520, Thailand
关键词
Fibrinolytic enzyme; Enzyme purification; Physiochemical properties; Statistical optimization; Fermentation; BACILLUS-AMYLOLIQUEFACIENS DC-4; AQUEOUS 2-PHASE SYSTEMS; SUBTILISSIMUS UCP 1262; CULTURE SUPERNATANT; BIOCHEMICAL-CHARACTERIZATION; ENHANCED PRODUCTION; SERINE-PROTEASE; INTRAMOLECULAR CHAPERONE; NATTOKINASE PRODUCTION; THROMBOLYTIC ACTIVITY;
D O I
10.1016/j.ijbiomac.2020.07.303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrinolytic enzymes are proteases responsible for cleavage of fibrin mesh in thrombus clots, which are the primary causative agents in cardiovascular diseases. Developing safe, effective and cheap thrombolytic agents are important for prevention and cure of thrombosis. Although a wide variety of sources have been discovered for fibrinolytic enzymes, only few of them have been employed in clinical and therapeutic applications due to the drawbacks such as high cost of production, low stability of enzyme or therapeutic side effects. However, the discovery of new fibrinolytic enzymes requires complex purification stages and characterization, which gives an insight into their diverse modes of action. Post-discovery, approaches such as a) statistical optimization for fermentative bioprocessing and b) genetic engineering are advantageous in providing economic viability by finding simple and cost-effective medium, strain development with sufficient nutrient supplements for stable and high-level production of recombinant enzyme. This review provides a comprehensive understanding of different sources, purification techniques, production through genetic engineering approaches and statistical optimization of fermentation parameters as proteases have a wide variety of industrial and biotechnological applications making 60% of total enzyme market worldwide. New strategies targeting increased enzyme yields, non-denaturing environments, improved stability, enzyme activity and strain improvement have been discussed. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:1498 / 1517
页数:20
相关论文
共 210 条
[1]   Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation [J].
Adeboyeje, Gboyega ;
Sylwestrzak, Gosia ;
Barron, John J. ;
White, Jeff ;
Rosenberg, Alan ;
Abarca, Jacob ;
Crawford, Geoffrey ;
Redberg, Rita .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09) :968-978
[2]   Microbial Enzymes: Tools for Biotechnological Processes [J].
Adrio, Jose L. ;
Demain, Arnold L. .
BIOMOLECULES, 2014, 4 (01) :117-139
[3]  
Afifah Diana Nur, 2014, Prev Nutr Food Sci, V19, P213, DOI 10.3746/pnf.2014.19.3.213
[4]   Characterization of a Novel Fibrinolytic Enzyme, BsfA, from Bacillus subtilis ZA400 in Kimchi Reveals Its Pertinence to Thrombosis Treatment [J].
Ahn, Min-Ju ;
Ku, Hye-Jin ;
Lee, Se-Hui ;
Lee, Ju-Hoon .
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 25 (12) :2090-2099
[5]   Static Magnetic Field Effects on Proteases With Fibrinolytic Activity Produced by Mucor Subtilissimus [J].
Albuquerque, Wendell ;
Nascimento, Thiago ;
Brandao-Costa, Romero ;
Fernandes, Thiago ;
Porto, Ana .
BIOELECTROMAGNETICS, 2017, 38 (02) :109-120
[6]   MECHANISM OF CLOT DISSOLUTION BY PLASMIN [J].
ALKJAERSIG, N ;
FLETCHER, AP ;
SHERRY, S .
JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (07) :1086-1095
[7]  
[Anonymous], 2012, FIBRINOLYTIC BACTERI, DOI DOI 10.1007/978-3-642-24980-8_1
[8]  
[Anonymous], 2024, Solidaris. pregnancy-and-birthEB/OL
[9]   Optimization of process parameters for the enhanced production of fibrinolytic enzyme by a newly isolated marine bacterium [J].
Anusree M. ;
Swapna K. ;
Aguilar C.N. ;
Sabu A. .
Bioresource Technology Reports, 2020, 11
[10]  
Arshad A, 2018, PAK J PHARM SCI, V31, P1597